DC Investments Management’s Pfizer PFE Stock Holding History

DC Investments Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,128	Closed	-$200K	–	71
2026 Q1	$200K	Buy	+7,128	New	+$190K	0.08%	75
2020 Q4	–	Sell	-9,307	Closed	-$324K	–	85
2020 Q3	$324K	Sell	9,307 -1,917	-17%	-$67.2K	0.35%	50
2020 Q2	$348K	Sell	11,224 -28,298	-72%	-$961K	0.13%	131
2020 Q1	$1.22M	Buy	39,522 +25,617	+184%	+$873K	0.99%	11
2019 Q4	$517K	Sell	13,905 -259	-2%	-$9.22K	0.4%	105
2019 Q3	$483K	Buy	14,164 +149	+1%	+$5.42K	0.28%	141
2019 Q2	$576K	Sell	14,015 -1,987	-12%	-$78.9K	0.32%	102
2019 Q1	$645K	Hold	16,002	–	–	0.41%	77
2018 Q4	$663K	Sell	16,002 -12,603	-44%	-$523K	0.54%	30
2018 Q3	$1.2M	Buy	28,605 +13,073	+84%	+$503K	0.81%	3
2018 Q2	$535K	Sell	15,532 -73,313	-83%	-$2.51M	0.34%	154
2018 Q1	$2.99M	Buy	88,845 +24,127	+37%	+$829K	2.01%	1
2017 Q4	$2.22M	Buy	+64,718	New	+$2.21M	0.92%	3

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DC Investments Management's PFE Position: Q2 2026 in Review

DC Investments Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,128 shares — an estimated $200K sold.

DC Investments Management first reported a position in PFE in Q4 2017 and held it in 13 quarters. The position peaked at $2.99M in Q1 2018. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

DC Investments Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
DC Investments Management sold 7,128 Pfizer shares in Q2 2026, an estimated $200K.
DC Investments Management first reported a position in Pfizer in Q4 2017 and held it in 13 quarters.
DC Investments Management's Pfizer position peaked at $2.99M in Q1 2018.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on DC Investments Management's 13F filing for Q2 2026, filed 14 Aug 2026.